Last update 05 Dec 2024

A-dmDT390-bisFv(National Institutes of Health)

Overview

Basic Info

Drug Type
Antibody toxin conjugate
Synonyms
A-dmDT390-anti-CD3 immunotoxin, Anti-CD3 antibody-diphtheria toxin conjugate, Anti-CD3 bivalent antibody-diphtheria toxin conjugate
+ [9]
Target
Mechanism
CD3 inhibitors(T cell surface glycoprotein CD3 inhibitors)
Originator Organization
Active Organization
Drug Highest PhasePhase 2
First Approval Date-
RegulationFast Track (US), Orphan Drug (US)
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic melanomaPhase 2
US
01 Feb 2014
Metastatic melanomaPhase 2
US
01 Feb 2014
Mycosis FungoidesPhase 2
US
01 Jan 2008
Sezary SyndromePhase 2
US
01 Jan 2008
T-Cell LeukemiaPhase 2
US
01 Jan 2008
Cutaneous T-Cell LymphomaPhase 2
US
-
Graft vs Host DiseasePhase 2
US
-
Solid tumorPhase 2
US
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
30
rwxxajgyls(zmstbmhjgf) = hgajwiulnn hsazfejjhe (oljyfzadmc, 18 - 57)
Positive
01 Jun 2015
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free